切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 71 -76. doi: 10.3877/cma.j.issn.1674-3903.2021.02.002

论著

他克莫司个体内变异及其相关因素对移植后肾功能不全的影响
万正利1, 李壹1, 李亚梅1, 安云飞1, 严琳1, 白杨娟1, 王兰兰1, 石运莹2,()   
  1. 1. 610000 成都,四川大学华西医院实验医学科免疫实验室
    2. 610000 成都,四川大学华西医院肾内科
  • 收稿日期:2020-08-20 出版日期:2021-04-25
  • 通信作者: 石运莹
  • 基金资助:
    国家自然科学基金(81771714)

Intra-individual variation of tacrolimus and its related factors on renal insufficiency after transplantation

Zhengli Wan1, Yi Li1, Yamei Li1, Yunfei An1, Lin Yan1, YangJuan Bai1, Lanlan Wang1, Yunying Shi2,()   

  1. 1. Laboratory of Immunology, West China Hospital of Sichuan University, Chengdu 610000, China
    2. Department of Nephrology, West China Hospital of Sichuan University, Chengdu 610000, China
  • Received:2020-08-20 Published:2021-04-25
  • Corresponding author: Yunying Shi
引用本文:

万正利, 李壹, 李亚梅, 安云飞, 严琳, 白杨娟, 王兰兰, 石运莹. 他克莫司个体内变异及其相关因素对移植后肾功能不全的影响[J/OL]. 中华移植杂志(电子版), 2021, 15(02): 71-76.

Zhengli Wan, Yi Li, Yamei Li, Yunfei An, Lin Yan, YangJuan Bai, Lanlan Wang, Yunying Shi. Intra-individual variation of tacrolimus and its related factors on renal insufficiency after transplantation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(02): 71-76.

目的

分析肾移植术后发生移植肾功能不全的影响因素,为实现移植肾长期存活提供经验。

方法

回顾性分析2013年1月至2015年12月在四川大学华西医院接受肾移植手术的592例受者临床资料,包括:供者性别、血清肌酐水平以及估算肾小球滤过率(eGFR);受者年龄、性别、民族、体质指数(BMI)、HBsAg、血清肌酐水平以及他克莫司个体内变异(Tac-IPV);供肾类型、HLA错配数。根据移植肾存活情况将受者分为移植肾功能不全组和移植肾功能稳定组。根据Tac-IPV中位数将受者分成高变异组(Tac-IPV≥32.1)和低变异组(Tac-IPV<32.1)。根据《中国成人超重和肥胖症预防控制指南》标准,将受者分为低BMI组(<18.5 kg/m2)、正常BMI组(18.5~<24 kg/m2)和高BMI组(≥24 kg/m2)。采用t检验或U检验比较供者捐献前血清肌酐水平和eGFR以及受者年龄、BMI、血清肌酐水平和Tac-IPV。将单因素分析中P<0.10的变量纳入Logistic回归多因素分析。采用Kaplan-Meier法绘制移植肾生存曲线并使用log-rank检验进行比较。采用Cox比例风险模型分析影响移植肾生存的危险因素。采用卡方检验比较供者性别以及受者性别、民族、HBsAg、供肾类型和HLA错配数。P<0.05为差异有统计学意义。

结果

592例肾移植受者平均年龄(33±9)岁(18~60岁),男性452例,女性140例;汉族519例,少数民族73例。移植肾功能稳定组和功能不全组分别纳入533例和59例受者。随访至2017年8月,592例受者平均随访时间为(30±11)个月(1~54个月)。移植肾功能稳定组受者性别、民族、BMI和Tac-IPV与移植肾功能不全组差异均有统计学意义(χ2/U=5.040、3.677、6.710和30.152,P均<0.05)。Logistic回归多因素分析结果提示,受者性别、民族、BMI和Tac-IPV是移植肾功能不全的独立危险因素(OR=0.308、1.101、2.246和137.369,P均<0.05)。女性受者移植肾存活率高于男性受者,Tac-IPV高变异组移植肾存活率低于低变异组,差异均有统计学意义(χ2=5.88和27.04,P均<0.05)。高BMI组受者移植肾存活率最低,低BMI组移植肾存活率低于正常BMI组,差异有统计学意义(χ2=8.071,P<0.05)。Cox比例风险模型分析结果显示,影响移植肾生存的危险因素分别为受者性别、民族、BMI和Tac-IPV(HR=2.934、0.506、51.291和1.077,P均<0.05)。

结论

早期发现并干预肾移植受者BMI和Tac-IPV,有助于维持移植肾长期存活,改善受者预后。

Objective

Factors of renal insufficiency after renal transplantation were analyzed to provide a better methods for the long-term survival of the graft.

Methods

Clinical data of 592 renal transplantation recipients in West China Hospital of Sichuan University from January 2013 to December 2015 were retrospectively analyzed, including gender of the donor, serum creatinine level and estimated glomerular filtration rate(eGFR); recipients age, gender, ethnicity, body mass index (BMI), HBsAg, serum creatinine level and Tacrolimus-intra patient variant (Tac-IPV); donor kidney type, HLA mismatch number. According to the survival of renal allografts, the recipients were divided into renal insufficiency group and stable renal allograft group. The recipients were divided into high variation group (Tac-IPV≥32.1) and low variation group (Tac-IPV<32.1) on the basis of the median of Tac-IPV. According to the Chinese Adult Overweight and Obesity Prevention and Control Guidelines, the recipients were divided into low BMI group (<18.5 kg/m2), normal BMI group (18.5-<24 kg/m2) and high BMI group (≥24 kg/m2). The t-test or U test was used to compare the donor′s pre-donation serum creatinine level, eGFR and the recipient′s age, BMI, serum creatinine level and Tac-IPV. Variables with P<0.10 in univariate analysis were included in multivariate Logistic regression analysis. Kidney allograft survival curves were plotted using the Kaplan-Meier method and compared using the Logrank test. Cox proportional hazards model was used to analyze the risk factors affecting renal allograft survival. Chi-square test was used to compare the donor′s gender and the recipient′s gender, ethnicity, HBsAg, donor kidney type, and number of HLA mismatches. P<0.05 was considered statistically significant.

Results

The average age of 592 renal transplantation recipients was (33±9) years (18-60 years), including 452 males and 140 females. There were 519 cases of Han nationality and 73 cases of ethnic minorities. 533 patients in the stable group and 59 patients in the insufficiency group were included, respectively. As of August 2017, the average follow-up time of the recipients was (30±11) months (1-54 months). The difference of gender, ethnicity, BMI and TC-IPV of recipients between the renal insufficiency group and stable renal allograft group were statistically significant (χ2/U=5.040, 3.677, 6.710 and 30.152, P all<0.05). Logistic regression multivariate analysis showed that gender, ethnicity, BMI and Tac-IPV of recipients were independent risk factors for renal graft dysfunction (OR=0.308, 1.101, 2.246 and 137.369, P all<0.05). The survival rate of transplanted kidney in female recipients was higher than that in male recipients, and the survival rate of transplanted kidney in the high-variation Tac-IPV group was lower than that in the low-variation Tac-IPV group, the differences were statistically significant (χ2=5.88 and 27.04, P all<0.05). The survival rate of transplanted kidney in the high BMI group was the lowest, and the survival rate of transplanted kidney in the low BMI group was lower than that in the normal group, the difference was statistically significant (χ2=8.071, P<0.05). Cox proportional risk model analysis showed that the risk factors affecting the survival of kidney transplantation were recipients gender, ethnicity, BMI and Tac-IPV (HR=2.934, 0.506, 51.291 and 1.077, P all<0.05).

Conclusion

Early detection and intervention of BMI and Tac-IPV can help to maintain the long-term survival of renal allografts and improve the prognosis of recipients.

表1 移植肾稳定组与肾功能不全组供受者临床资料比较结果
表2 移植肾功能不全影响因素Logistic回归多因素分析
图1 不同性别、民族、BMI和Tac-IPV肾移植受者移植肾生存曲线
表3 移植肾功能不全影响因素Cox比例风险模型分析
1
石炳毅,陈莉萍. 中国肾移植排斥反应临床诊疗指南(2016版)[J]. 器官移植,2016, 7(5):332-338.
2
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612.
3
中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录)[J]. 营养学报,2004, 26(1):1-4.
4
王淏. 肾移植术后抗HLA抗体的变化特征及长期动态监测的临床价值[D]. 苏州:苏州大学,2018.
5
崔瀚文,蔡明,袁清,等. 少数民族与汉族肾移植受者术后情况比较[J]. 解放军医学杂志,2013, 38(4):313-315.
6
Małgorzewicz S, Dębska-Slizień A, Czajka B, et al. Influence of body mass on kidney graft function in patients after kidney transplantation[J]. Transplant Proc, 2016, 48(5):1472-1476.
7
Liese J, Bottner N, Büttner S, et al. Influence of the recipient body mass index on the outcomes after kidney transplantation[J]. Langenbecks Arch Surg, 2018, 403(1):73-82.
8
逯霞. 活体肾移植术后短期慢性移植肾失功影响因素分析[D].新疆:新疆医科大学,2009.
9
贾英斌,张勇. 移植肾慢性排斥反应的免疫机制和危险因素[J]. 第一军医大学学报,2001, 21(10):792-793.
10
Mo H, Kim SY, Min S, et al. Association of intrapatient variability of tacrolimus concentration with early deterioration of chronic histologic lesions in kidney transplantation[J]. Transplant Direct, 2019, 5(6):e455.
11
Schumacher L, Leino AD, Park JM. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective[J]. Pharmacotherapy, 2021, 41(1):103-118.
12
Manski CF, Tambur AR, Gmeiner M. Predicting kidney transplant outcomes with partial knowledge of HLA mismatch[J]. Proc Natl Acad Sci U S A, 2019, 116(41):20339-20345.
13
杨小晖. 活体亲属肾移植供肾体积与移植肾长期存活相关性研究[D]. 昆明:昆明医科大学,2012.
14
赵霞娟,陆福明. 慢性移植物肾病的研究现状[J]. 内科理论与实践,2008, 3(3):203-206.
15
Miles AM, Sumrani N, John S, et al. The effect of kidney size on cadaveric renal allograft outcome[J]. Transplantation, 1996, 61(6):894-897.
16
陈锦,李黔生,叶锦,等. 慢性移植肾失功356例危险因素分析[J]. 中国组织工程研究与临床康复,2007, 11(51):10356-10358.
17
Yazici B, Bulut IK, Oral A, et al. Early predictive value of baseline renal transplant scintigraphy in pediatric patients[J]. Nucl Med Commun, 2018, 39(10):901-907.
18
贺媛,曾强,赵小兰. 中国成人体质指数、年龄与血压水平相关性分析[J]. 中国公共卫生,2016, 32(1):69-72.
19
张大伟,许亮,徐俊楠,等. 肾移植受者术前甘油三酯代谢对移植肾早期功能恢复的影响[J]. 解放军医学杂志,2017, 42(5):427-443
20
马潞林. 慢性移植肾失功的原因和影响因素[J]. 中国血液净化,2003, 2(11):593-593, 617.
21
Tsujita M, Goto N, Futamura K, et al. Triglyceride metabolism in Japanese kidney transplant recipients[J]. Clin Exp Nephrol, 2018, 22(2):459-464.
22
Baldwin WM 3rd, Valujskikh A, Fairchild RL. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts[J]. Curr Opin Organ Transplant, 2016, 21(1):7-14.
23
李玲,李宁,艾紫叶,等. 器官移植预后预测新指标:患者他克莫司浓度个体内的变异性[J]. 中国组织工程研究,2016, 20(49):7437-7442.
24
中华医学会器官移植学分会. 他克莫司在临床肝移植中的应用指南[J]. 临床肝胆病杂志,2015, 31(9):1372-1374.
25
孟中如,朱怀军,葛卫红. 他克莫司个体内浓度变异度与肝肾移植预后关系的研究进展[J]. 药学与临床研究,2018, 26(4):278-280, 286.
26
Stefanović NZ, Veličković-Radovanović RM, Danković KS, et al. Combined effect of inter- and intrapatient variability in tacrolimus exposure on graft impairment within a 3-year period following kidney transplantation: A single-center experience[J]. Eur J Drug Metab Pharmacokinet, 2020, 45(6):749-760.
27
Kuypers DRJ. Intrapatient variability of tacrolimus exposure in solid organ transplantation: A novel marker for clinical outcome[J]. Clin Pharmacol Ther, 2020, 107(2):347-358.
28
Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management[J]. Transplant Rev (Orlando), 2015, 29(2):78-84.
29
Gonzales HM, McGillicuddy JW, Rohan V, et al. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation[J]. Am J Transplant, 2020, 20(8):1969-1983.
[1] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[2] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[3] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[4] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[5] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[6] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[7] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[8] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[9] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[10] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[11] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[12] 单良, 刘怡, 于涛, 徐丽. 老年股骨颈骨折术后患者心理弹性现状及影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 294-300.
[13] 王如海, 王绅, 张敏, 李春, 韩超, 于强, 胡海成, 李习珍. 重型创伤性脑损伤患者去骨瓣减压术后短期死亡风险的影响因素分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 285-291.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 黄晓云, 姚雅极. 院前急救医师职业寿命影响因素与对策思考[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 281-285.
阅读次数
全文


摘要